Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Gordon Gary B. | May 15, 2026 | Buy | $24.6K | 10,000 |
| CFO | Patience David | May 15, 2026 | Buy | $17.25K | 7,100 |
| Director | Stansky Michael P | May 15, 2026 | Buy | $1.03M | 410,000 |
| CEO | Szela Mary T | May 15, 2026 | Buy | $102.78K | 39,682 |
| Chief Commercial Officer | Marshak Richard | May 15, 2026 | Sell | $1.45K | 543 |
| Director | Wahlstrom Mats | May 15, 2026 | Buy | $151.8K | 60,000 |
| Director | Stansky Michael P | May 15, 2026 | Buy | $500K | 200,000 |
| CEO | Szela Mary T | Mar 17, 2026 | Sell | $61.38K | 15,944 |
| Chief of Clinical Operations | Devlin Jodi | Mar 16, 2026 | Sell | $1.12K | 273 |
| Chief of Research | Cox Bryan F. | Mar 16, 2026 | Sell | $2.39K | 579 |
| Chief Regulatory Officer | Stevens Jennifer | Mar 16, 2026 | Sell | $3.19K | 774 |
| Chief Commercial Officer | Marshak Richard | Mar 16, 2026 | Sell | $1.73K | 419 |
| Chief of Research | Cox Bryan F. | Mar 12, 2026 | Sell | $6K | 1,467 |
| Chief Regulatory Officer | Stevens Jennifer | Mar 12, 2026 | Sell | $6.35K | 1,552 |
| Chief Commercial Officer | Marshak Richard | Mar 12, 2026 | Sell | $6.5K | 1,589 |
| Chief of Clinical Operations | Devlin Jodi | Mar 12, 2026 | Sell | $7.25K | 1,772 |
| CEO | Szela Mary T | Mar 11, 2026 | Sell | $18K | 4,358 |
| Chief Regulatory Officer | Stevens Jennifer | Mar 11, 2026 | Sell | $4.97K | 1,204 |
| Chief of Research | Cox Bryan F. | Mar 11, 2026 | Sell | $4.7K | 1,138 |
| Chief of Clinical Operations | Devlin Jodi | Mar 11, 2026 | Sell | $4.8K | 1,162 |
| Chief Commercial Officer | Marshak Richard | Mar 11, 2026 | Sell | $5.98K | 1,449 |
| Director | Gordon Gary B. | Feb 23, 2026 | Buy | $40K | 9,756 |
| CEO | Szela Mary T | Feb 23, 2026 | Buy | $125K | 30,487 |
| Director | Valle William | Feb 23, 2026 | Buy | $125K | 30,487 |
| Director | Stansky Michael P | Feb 23, 2026 | Buy | $999.99K | 243,900 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
